Editorial
 THE ACHILLES' HEEL OF API   
 Wednesday, May 16, 2018 
 The Central government has constituted yet another high-level task force, this time headed by Union Minister of State for Chemicals and Fertilisers, to formulate a roadmap for the enhanced production of active pharmaceutical ingredients in the country. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]Clinical trial published in JAMA offers new hope for COPD patients
17:30  [IST]Cipla posts consolidated net profit of Rs. 153 cr in Q4
17:00  [IST]Amgen receives US FDA approval for Prolia to treat glucocorticoidi-induced osteoporosis
16:00  [IST]Oasmia Pharma completes spin-off of veterinary oncology assets to its US subsidiary, AdvaVet
15:30  [IST]EXIM Bank releases study entitled ‘Enhancing India’s Engagement in Healthcare Sector of CLMV Countries’
15:10  [IST]Dr Reddy's Labs' sales and profit under pressure in Q4, dividend at 400%
more news >>
TOP NEWS
08:00  [IST]Ayush drug makers don’t need analytical test report to take part in public procurement tenders; govt move to boost MSMEs
08:00  [IST]PDMA moves Punjab HC against joint inspection of pharma units by CDSCO & state drug inspectors
08:00  [IST]DTAB approves DCGI's proposal for introducing unique code to drug packs to curtail spurious drugs in domestic market
08:00  [IST]Health ministry to integrate mobile app for reporting ADR with global regulators to enhance pharmacovigilance
08:00  [IST]Nipah Virus may have come to Kerala through migratory fruits-eating bats from Indonesia, says Dr Jacob John
08:00  [IST]Reine Lifescience gets US FDA warning letter for flouting cGMP norms for APIs; second Gujarat firm to face heat this year
more news >>
YESTERDAY'S NEWS
18:00  [IST]RXi Pharma reports positive results from phase 2 study of Samcyprone to treat common warts
17:00  [IST]NIH statement on HIV Vaccine Awareness Day
16:20  [IST]CPhI’s 7th Annual Innopack Pharma Confex to be held in Mumbai from May 24 – 25
16:00  [IST]Aquestive settles Suboxone patent infringement litigation with Par Pharma
15:00  [IST]EMA review of Zinbryta confirms medicine’s risks outweigh its benefits
14:00  [IST]Researchers suggest microglia key defenders against prion diseases
more news >>
INTERVIEW  
Indian Pharma Inc shifts to high gear in filing patents
Ruhan Rajput, Director, Einfolge.
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the central govt's decision to replace MCI with National Medical Commission boost the medical education scenario in the country?
 
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
IPE_2018_Banner_150X60
InnoPack-Pharma_150x60_2018
GPRS_150x60_2018
cphikorea_150x60_saffron media
Chemspec_India-2018
IPX_Logo_2018_150x60_web
CPHI18_banner_150x6
CPhI_China_150x60-2018
PharmaTech_Expo_2018
VF118_Banner_150x60_E_D2
duphat_150x60
IPJPI18_150x60en_2018
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |